WallStSmart
BYSI

BeyondSpring Inc

NASDAQ: BYSI · HEALTHCARE · BIOTECHNOLOGY

$1.52
+0.00% today

Updated 2026-06-05

Market cap
$71.55M
P/E ratio
P/S ratio
45.99x
EPS (TTM)
$-0.25
Dividend yield
52W range
$1 – $3
Volume
0.0M

BeyondSpring Inc (BYSI) Financial statements

SEC filings — annual and quarterly data.

Profit margin
0.00%
Operating margin
0.00%
ROE
-310.50%
ROA
-19.30%
Debt/equity
-0.01x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2014$0.00$-3.01M
2015$0.00$-7.97M
2016$0.00$-12.01M
2017$0.00$-91.76M
2018$0.00$-54.87M
2019$0.00$-38.09M
2020$180000.00$-60.97M100.00%-35,672.78%-33,873.89%
2021$1.35M$-64.18M100.00%-4,903.03%-4,750.48%
2022$1.35M$-33.28M100.00%-2,756.40%-2,463.29%
2023$1.75M$-21.03M-17.25%-861.28%-1,200.80%
2024$0.00$-11.12M
2025$0.00$-7.99M

Frequently asked questions

What is BeyondSpring Inc's revenue?

BeyondSpring Inc's trailing twelve-month revenue is $1.88M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How much free cash flow does BYSI generate?

BYSI produced $-20.07M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is BYSI's balance sheet healthy?

BYSI holds $7.79M in cash and equivalents against — in long-term debt, on $-32.16M of shareholder equity. That debt is best read against the cash flow the business throws off each year.